NASDAQ update:Hopper restarted the RAD-NASDAQ-Listing after he,...

NASDAQ update:

Hopper restarted the RAD-NASDAQ-Listing after he, US pharma giant Lantheus and a few US funds secured about 90% of RAD.

According to Friday's RAD anns it will be done by 1 US for 200 ASX shares ADR to deal with the now up to 2.5b RAD shares. No $$$ raised, just listing and hoping the ADR will increase demand here and the US will set a higher price as similar staged peers are valued over there up to 100 times higher.

CHM will soon follow as its register gets a makeover similar to RAD in the next 6-7 weeks.
CHM's now promoted to top priority asset CDH 17, similar to CD19 CAR-T, but able to attack a variety of SOLID gastric cancers, has recently been much published about and it is very likely to attrack a CAR-T powerhouse.

If both listings get done and show a valuation increase PH will certainly do the same here.

In 6 months we will get a better picture about that.

GLTA